Drug ID: | NPD6203 |
Drug Name: | |
Molecular Formula: | C25H25N3O |
Canonical SMILES: | OC(=NCc1c[nH]c2c1cccc2)[C@@H]1CCCN1Cc1cccc2c1cccc2 |
Standard InCHI: | InChI=1S/C25H25N3O/c29-25(27-16-20-15-26-23-12-4-3-11-22(20)23)24-13-6-14-28(24)17-19-9-5-8-18-7-1-2-10-21(18)19/h1-5,7-12,15,24,26H,6,13-14,16-17H2,(H,27,29)/t24-/m0/s1 |
Standard InCHIKey: | CUWTVICBYHBSOX-DEOSSOPVSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB006486 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 383.20 |
ALogP | -1.4113 |
MLogP | 3.77 |
XLogP | 6.975 |
HDA | 4 |
HBD | 2 |
Rotatable Bonds | 6 |
TPSA | 51.62 |
RO5 Violation | 1 |